Low Risk of Producing an Opioid Use Disorder in Primary Care by Prescribing Opioids to Prescreened Patients with Chronic Noncancer Pain. – PubMed – NCBI – 2017 Mar
Here’s the main finding of this study:
Less than 5% of our study population
revealed any evidence of substance use disorder.
To examine the risk of developing aberrant behaviors that might lead to a substance use disorder (addiction) when prescribing opioids for the relief of chronic noncancer pain in primary care settings. Continue reading
Chronic pain and opioid misuse: a review of reviews – Open Access (free full-text) – August 2017
The review found a high rate of pre-existing pain among non-medical Rx opioid users and found only a low level of opioid use disorder among pain patients.
The crisis of prescription opioid (PO) related harms has focused attention toward identifying and treating high-risk populations. This review aims to synthesize systematic reviews on the epidemiology and clinical management of comorbid chronic pain and PO or other substance misuse.
A systematic database search was conducted to identify systematic reviews published between 2000 and 2016. Continue reading
10 Things My Chronic Illness Taught My Children – The New York Times – Paula M. Fitzgibbons – DISABILITY AUG. 16, 2017
My children have a mother with a chronic illness. They live with my rheumatoid arthritis just as much as I do.
I was given my diagnosis when all three of them were young, and since then I’ve spent a lot of time worrying about what the daily uncertainty of my condition would mean to them, and whether it would affect their development.
They are all teenagers now, one getting ready for college, and I can attest that my illness has indeed affected them. Here’s how. Continue reading
FDA Declares CBD ‘Beneficial,’ Wants Your Input ASAP – by Bruce Barcott – August 14, 2017
The United Nations is trying to figure out how to categorize cannabidiol (CBD), a non-psychoactive and medically beneficial cannabinoid contained in cannabis. And UN officials, through the US Food and Drug Administration (FDA), are asking for your help.
The FDA declared that
‘CBD has been shown to be beneficial.’
Now the agency needs your comments to back it up.
All those who have information on, or experience with, the use of CBD as a healing substance are encouraged to comment at this federal website. Continue reading
Study Answers Why Ketamine Helps Depression, Offers Target for Safer Therapy – June 21, 2017
UT Southwestern Medical Center scientists have identified a key protein that helps trigger ketamine’s rapid antidepressant effects in the brain, a crucial step to developing alternative treatments to the controversial drug being dispensed in a growing number of clinics across the country.
Ketamine is drawing intense interest in the psychiatric field after multiple studies have demonstrated it can quickly stabilize severely depressed patients.
But ketamine – sometimes illicitly used for its psychedelic properties – could also impede memory and other brain functions, spurring scientists to identify new drugs that would safely replicate its antidepressant response without the unwanted side effects. Continue reading
8 Facts about Expired Medications – April, 2017
Yes, it’s fine to take medications long after their expiration date, especially if they’ve been stored properly. That date is only for legal liability purposes.
Many medications are very expensive and people hate to waste them. To avoid a costly visit to the doctor for a new prescription, many people have to consume expired drugs.
Physicians and pharmaceutical companies, because of legal restrictions and liability concerns, will not sanction such use and may not even comment on the safety or effectiveness of using their products beyond the date on the label. Continue reading
Opioids in chronic noncancer pain: More faces from the crowd | Pain Res Manag | Jul-Aug 2012 | C Peter N Watson, MD FRCPC | free full-text PMC3411376
The present article contains 17 case reports of 11 CNCP conditions (followed to 2011) selected to illustrate specific issues from a survey of 84 patients with intractable CNCP treated with opioids and followed every three months for a median of 11 years.
Most patients in the total sample reported 50% or greater relief and a moderate improvement in disability.
Problematic use, tolerance and serious adverse effects, including constipation, were not major issues. Continue reading
Guidelines for the Chronic Use of Opioid Analgesics from State Medical Boards – Opioid Guidelines As Adopted April 2017_FINAL.pdf
Adopted as policy by the Federation of State Medical Boards April 2017
In April 2015, the Federation of State Medical Boards (FSMB) Chair, J. Daniel Gifford, MD, FACP, appointed the Workgroup on FSMB’s Model Policy for the Use of Opioid Analgesics in the Treatment of Chronic Pain to review the current science for treating chronic pain with opioid analgesics and to revise the Model Policy as appropriate.
In updating its existing policy, the FSMB sought input from a diverse group of medical and policy stakeholders that ranged from experts in pain medicine and addiction to government officials and other thought leaders.
This what the CDC should have done as well, but did not. Continue reading
» call MORGAN & MORGAN ..tell your story… refer to chronic pain patient class action PHARMACIST STEVE June 19, 2017 by Steve Ariens
Chronic Pain Patients – Call Now
Morgan & Morgan Lawyers
Ask for the medical malpractice department.
Refer to chronic pain patient class action and tell your story. Continue reading
Let’s not kill pain patients to “save” patients with addiction.
– @StefanKertesz on Twitter
As a physician, I urge caution as we cut back opioids | TheHill | By Dr. Stefan G Kertesz – Mar 28, 2017
“If all we talk about is a pill, for or against,
we are having the wrong conversation.
We don’t take care of prescription pads.
We take care of people.” Continue reading